Elevate Uranium Ltd

Company Profile

Elevate Uranium Ltd had its IPO on under the ticker symbol ELVUF.

The company operates in the Energy sector and Uranium industry. Elevate Uranium Ltd has a staff strength of 0 employees.

Stock update

Shares of Elevate Uranium Ltd opened at $0.31 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.31 - $0.34, and closed at $0.34.

This is a +2.19% increase from the previous day's closing price.

A total volume of 18,000 shares were traded at the close of the day’s session.

In the last one week, shares of Elevate Uranium Ltd have increased by +23.64%.

Elevate Uranium Ltd's Key Ratios

Elevate Uranium Ltd has a market cap of $68.87 million, indicating a price to book ratio of 5.9359 and a price to sales ratio of 1136.9342.

In the last 12-months Elevate Uranium Ltd’s revenue was $57243 with a gross profit of $116860 and an EBITDA of $-7051496. The EBITDA ratio measures Elevate Uranium Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Elevate Uranium Ltd’s operating margin was -13203.73% while its return on assets stood at -26.61% with a return of equity of -44.35%.

In Q2, Elevate Uranium Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 1400.7%.

Elevate Uranium Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Elevate Uranium Ltd’s profitability.

Elevate Uranium Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -10.4429. Its price to sales ratio in the trailing 12-months stood at 1136.9342.

Elevate Uranium Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$19.33 million

Total Liabilities

$675470.00

Operating Cash Flow

$-22684.00

Capital Expenditure

$17074

Dividend Payout Ratio

0%

Elevate Uranium Ltd ended 2025 with $19.33 million in total assets and $0 in total liabilities. Its intangible assets were valued at $19.33 million while shareholder equity stood at $18.49 million.

Elevate Uranium Ltd ended 2025 with $0 in deferred long-term liabilities, $675470.00 in other current liabilities, 80765712.00 in common stock, $-60616180.00 in retained earnings and $0 in goodwill. Its cash balance stood at $15.81 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Elevate Uranium Ltd’s total current assets stands at $15.90 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $59581.00 compared to accounts payable of $38975.00 and inventory worth $0.

In 2025, Elevate Uranium Ltd's operating cash flow was $-22684.00 while its capital expenditure stood at $17074.

Comparatively, Elevate Uranium Ltd paid $0 in dividends in 2025.

Other key metrics

Current Trading Price

$0.34

52-Week High

$0.4394

52-Week Low

$0.1759

Analyst Target Price

$

Elevate Uranium Ltd stock is currently trading at $0.34 per share. It touched a 52-week high of $0.4394 and a 52-week low of $0.4394. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.24 and 200-day moving average was $0.25 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 1666.7% of the company’s stock are held by insiders while 1034.6% are held by institutions.